Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

Exercise improves quality of life and sleep in ovarian cancer patients, with moderate and significant benefits, respectively. Methodological variability and high heterogeneity in trials highlight the ...

A mix of expected sequels and out-of-nowhere indie gems made 2025 a joy.

Individuals with a rare form of epilepsy treated with fenfluramine experienced significantly greater seizure reduction as ...

Plants vs. Zombies: Replanted is the definitive version of the original game, combining 2009’s PC version with content from ...

The United States is revamping its H-1B visa lottery system, prioritizing high-skilled, high-paid workers over a random ...

Adjuvant carboplatin added to standard anthracycline/taxane chemotherapy significantly improves outcomes in early ...

H-2B program is used by American companies to hire foreign nationals for temporary non-agricultural occupations in the United ...

Data included more than a million participants to find that Alzheimer's risk was up to 76% lower in these cases.